CJC-1295 + Ipamorelin is a co-lyophilized research blend of a GHRH analog and a selective growth hormone secretagogue, studied together for complementary growth-hormone-axis signaling. For research use only, not for human consumption.
$65.00
2 Vials
5% Off
3 Vials
8% Off
5 Vials
12% Off
In stock
CJC-1295 + Ipamorelin is a co-lyophilized research blend that combines two of the most widely studied growth hormone secretagogues. CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH), also known as modified GRF 1-29, while Ipamorelin is a selective pentapeptide growth hormone secretagogue and ghrelin (GHS-R1a) receptor agonist. The two are often studied together in preclinical research because they act on complementary parts of the growth hormone axis: CJC-1295 at the GHRH receptor and Ipamorelin at the GHS receptor.
This combination is a common subject of in-vitro and animal research into growth-hormone-secretagogue pharmacology, receptor signaling, and regulation of the somatotropic (GH/IGF-1) axis. Supplied as a research-grade, co-lyophilized powder for laboratory use only.
Related research: CJC-1295 research overview and Ipamorelin research overview.



